ALLIANCE CAPITAL MANAGEMENT L P 13D/13G Filings for BioXcel Therapeutics, Inc. (BTAI)

ALLIANCE CAPITAL MANAGEMENT L P 13D and 13G filings for BioXcel Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-13
7:09 pm
Sale		 2023-02-14 13G BioXcel Therapeutics, Inc.
BTAI		 ALLIANCE CAPITAL MANAGEMENT L P 2,471
0.100%		 -90,627decrease
(-97.35%)		 Filing
2022-02-14
4:02 pm
Purchase		 2022-02-14 13G BioXcel Therapeutics, Inc.
BTAI		 ALLIANCE CAPITAL MANAGEMENT L P 93,098
5.400%		 93,098increase
(New Position)		 Filing